Leveraging Partnerships With Drug Manufacturers To Overcome 340B Restrictions On Specialty Drugs
Proxsys Rx
DECEMBER 11, 2023
At the same time, it’s no secret that, since the advent of 340B ESP in 2020, the drug manufacturers have imposed a raft of restrictions on 340B program savings that exist far outside the letter of the law as written by Congress in 1992. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.
52 
Let's personalize your content